Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis.
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005050:Etretinate / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D027383:Papillomaviridae; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*; D014212:Tretinoin / Q000031:analogs & derivatives*; D014412:Tumor Virus Infections / Q000188:drug therapy*
D014212:Tretinoin; D005050:Etretinate